Skip to main content

Increased serum iron and iron saturation without liver iron accumulation distinguish chronic hepatitis C from other chronic liver diseases

Abstract

One hundred twenty-three patients with chronic liver diseases of various etiologies were evaluated for their iron status. The patients were divided into four distinct groups: chronic hepatitis C (63), chronic hepatitis B (14), B + C (3) and nonviral chronic liver diseases (43). In 107 patients (87%) the chronic liver disease was confirmed by biopsy. Mean serum iron (±sd) levels in the above four groups were: 166 ± 62, 103 ± 52, 142 ± 48, and 115 µg/dl; iron-binding capacity was 346 ± 80, 325 ± 72, 297 ± 27, and 374 ± 75 µg/dl, and iron saturation 50 ± 18, 32 ± 16, 48 ± 16, and 28 ± 10%, respectively. Serum ferritin, increased in all four groups, was highest in HCV; however, no evidence of hepatic iron accumulation could be found in any of the patients. There were no significant differences in liver function parameters measured in the four groups. We conclude that serum iron, iron saturation, and ferritin are increased in patients with hepatitis C in comparison to hepatitis B or other nonviral, nonhemochromatotic liver diseases. The increased iron status in hepatitis C patients is not manifested by increased liver iron. Awareness of these distinct features of chronic hepatitis C is essential in the diagnosis and treatment of chronic liver diseases.

This is a preview of subscription content, access via your institution.

References

  1. Bacon BR, Tavill AS: The role of the liver in normal iron metabolism. Semin Liver Dis 4:181–192, 1984

    PubMed  Google Scholar 

  2. Di Bisceglie AM, Axiotis CA, Hoofnagle JH, Bacon BR: Measurements of iron status in patients with chronic hepatitis. Gastroenterology 102:2108–2113, 1992

    PubMed  Google Scholar 

  3. Arber N, Konikoff FM, Hallak A, Halpern Z, Gilat T: Chronic hepatitis C virus infection is associated with increased serum iron, iron saturation and iron absorption, but no increased liver iron accumulation. Gastroenterology 104:872A, 1993

    Google Scholar 

  4. D'Alba R, Piperno A, Fargino L, Roffi L, Fracanazani AL, Pozzi M, Morena R, Fiorelli G: Increased iron stores are a common finding in chronic viral hepatitis. Hepatology 18:228A, 1993

    Google Scholar 

  5. Ishak KG: New developments in diagnostic liver pathology.In Pathogenesis of Liver Diseases: IAP Monograph No. 28. Baltimore, Williams and Wilkins, 1987, pp 223–373

    Google Scholar 

  6. Rowe JW, Wands JR, Mezey E, Waterbury LA, Wright JR, Tobin J, Andres R: Familial hemochromatosis; characteristic of the precirrhotic stage in a large kindred. Medicine 56:197–211, 1977

    PubMed  Google Scholar 

  7. Prieto J, Barry M, Sherlock S: Serum ferritin in patients with iron overload and with acute and chronic liver diseases. Gastroenterology 68:525–533, 1975

    PubMed  Google Scholar 

  8. Arber N, Moshkowitz M, Konikoff F, Halpern Z, Hallak A, Santo M, Tiomny E, Baratz M, Gilat T: Iron overload in patients with chronic HCV infection predicts a poor response to interferon treatment. Dig Dis Sci (in press)

  9. Piperano A, D'Alba R, Roffi L, Fargion S, Manica G, Fiorelli G: Relation between alfa interferon response and liver iron stores in chronic hepatitis C. Hepatology 18:250A, 1993

    Google Scholar 

  10. Perez R, Pravia R, Linares A, Rodriguez M, Lambrana JL, Suarez A, Riestra S, Navascues CA, Rodrigo L: Response related factors in recombinant interferon alfa-2b treatment of chronic hepatitis C. Gut Suppl:S139–S140, 1993

  11. Farinati F, Cardin R, De Maria N, Lecis E, Marafin C, Burra P, Naccarato R: HCV infection correlates with increased serum ferritin, hepatic iron and lipoperoxidation. Gastroenterology 104:23A, 1993

    Google Scholar 

  12. Chapman RW, Morgan MY, Laulicht M, Hoffbrand AV, Sherlock S: Hepatic iron stores and markers of iron overload in alcoholics and patients with hemochromatosis. Dig Dis Sci 27:909–916, 1982

    PubMed  Google Scholar 

  13. LeSage GD, Baldus WP, Fairbanks VF, Baggenstoss AH, McCall JT, Moore SB, Taswell HF, Gordon H: Hemochromatosis: Genetic or alcohol-induced? Gastroenterology 84:1471–1477, 1983

    PubMed  Google Scholar 

  14. Konikoff F, Shoenfeld Y, Isenberg DA, Theodor E, Moroz CH: Placental type isoferritins in chronic liver diseases. Hepato-Gastroenterol 34:65–67, 1987

    Google Scholar 

  15. Konijn AM, Hershko C: Ferritin synthesis in inflammation. I. Pathogenesis of impaired iron release. Br J Haematol 37:7–16, 1977

    PubMed  Google Scholar 

  16. Hershko C, Peto TEA, Weatherall DJ: Iron and infection. Br Med J 296:660–664, 1988

    Google Scholar 

  17. Parenterally acquired non-A,non-B (type C) hepatitis.In Oxford Textbook of Clinical Hepatology, Vol 1, 4th ed. N McIntyre (ed). New York, Oxford University Press 1991, pp 605–615

    Google Scholar 

  18. Dusheiko G, Hoofnagle J. Hepatitis B:In Oxford Textbook of Clinical Hepatology, Vol 1, 4th ed. N McIntyre (ed). New York, Oxford University Press, 1991, pp 575–588

    Google Scholar 

Download references

Author information

Affiliations

Authors

Additional information

Part of this work has been previously published in an abstract from (Gastroenterology 104:872A, 1993).

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Arber, N., Konikoff, F.M., Moshkowitz, M. et al. Increased serum iron and iron saturation without liver iron accumulation distinguish chronic hepatitis C from other chronic liver diseases. Digest Dis Sci 39, 2656–2659 (1994). https://doi.org/10.1007/BF02087705

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02087705

Key words

  • hepatitis
  • iron
  • hemochromatosis
  • HCV
  • HBV
  • chronic liver disease